Currently submitted to: Journal of Medical Internet Research
Date Submitted: Mar 25, 2026
Open Peer Review Period: Mar 25, 2026 - May 20, 2026
(currently open for review)
Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
How AI Chatbots Choose Medical Solutions: A Discrete Choice Experiment
ABSTRACT
Background:
The proliferation of artificial intelligence chatbots within the contemporary healthcare ecosystems represents a paradigmatic shift toward enhanced accessibility and operational efficiency. Nevertheless, extant human-computer interaction demonstrates substantial deficiencies in addressing users' core needs and value propositions. A critical lacuna emerges in understanding the heterogenous prioritization mechanisms employed by disparate AI chatbots attributes when synthesizing recommendations – a phenomenon conceptualized herein "AI response preference."
Objective:
This study aims to conduct a comprehensive quantitative assessment of response predispositions exhibited by six mainstream AI chatbots within medical communication contexts, while systematically elucidating their intrinsic preference architectures and underlying algorithmic internal weights.
Methods:
The Discrete Choice Experiment was systematically constructed utilizing seven key communication attributes as foundational parameters. Each experimental model underwent iterative implementation across 150 replications to ensure statistical robustness. The data employed mixed logit modeling frameworks to derive correlation coefficient (β), relative importance (RI), odds ratios (OR), and utility values, thereby facilitating comprehensive preference structure elucidation.
Results:
The AI chatbots demonstrated pronounced positive preference orientations, exhibiting particularly robust predilections toward dimensions encompassing elevated empathetic and psychosocial support provision, diagnostic precision and information veracity, and the clarity and feasibility of treatment suggestions. Conversely, preference coefficients for response latency and privacy cognizance manifested comparatively attenuated magnitudes. Significant inter-model heterogeneity in attribute-specific relative importance weightings was empirically observed across the different models: ChatGPT emphasized on monetary valuation parameters, Gemini prioritized primacy toward diagnostic accuracy optimization, Grok and DeepSeek manifested concentrated focus on communicative excellence and affective resonance, Doubao emphasized the clarity of treatment suggestions, whereas Wenxinyiyan displayed bifurcated emphasis encompassing both monetary considerations and treatment precision metrics. Subsequent willingness-to-pay analytical decomposition corroborated these differentiated value hierarchies and preference stratifications.
Conclusions:
Current AI chatbots exhibit significant systematic biases in their response generation within the medical field, overemphasizing disproportionate valorization of technical proficiency and actionable attributes while concurrently neglecting humanistic dimensions particularly privacy preservation and communicative fluency. The conceptual framework of algorithmic response bias emerges as a pivotal evaluative metric for assessing human-machine value congruence, thereby catalyzing the advancement of medical AI systems characterized by diagnostic precision, empathetic resonance, and epistemic trustworthiness.
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.